Cargando…
Finding the mutations that drive resistance
Mutations that allow tumors to evolve and become resistant to treatment can be readily identified with a new sequencing approach.
Autor principal: | Bley, Nadine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228763/ https://www.ncbi.nlm.nih.gov/pubmed/32408944 http://dx.doi.org/10.7554/eLife.57678 |
Ejemplares similares
-
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation
por: Halstead, Angela M, et al.
Publicado: (2017) -
Driving cancer evolution
por: Fitzgerald, Devon M, et al.
Publicado: (2017) -
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer
por: Shah, Neel, et al.
Publicado: (2017) -
SATB2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistance
por: Fazio, Maurizio, et al.
Publicado: (2021) -
Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance
por: Anantha, Rachel W, et al.
Publicado: (2017)